FrancophonIA/ELRC3.0 huggingface dataset:
English: Twinrix Paediatric is a vaccine used in infants, children and adolescents from 1 year up to and including 15 years to prevent two diseases: hepatitis A and hepatitis B. The vaccine works by causing the body to produce its own protection (antibodies) against these diseases.
Croatian: Što je Twinrix Paediatric i za što se koristi Twinrix Paediatric je cjepivo namijenjeno za primjenu u djece i adolescenata od navršene 1. godine života do uključivo 15. godine, u svrhu prevencije dviju bolesti: hepatitisa A i hepatitisa B.
English: Uncommon (these may occur with up to 1 in 100 doses of the vaccine)
Croatian: Manje česte (mogu se javiti kod do 1 na 100 doza cjepiva):
English: QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose (0.5 ml) contains:
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV 1 doza (0,5 ml) sadrži: inaktivirani virus hepatitisa A 1,2
English: GlaxoSmithKline BV Tel: + 31 (0)30 69 38 100 nlinfo@gsk.com
Croatian: GlaxoSmithKline BV Tel: + 31 (0)30 69 38 100
English: At 10 years following the initiation of a 0, 1, 6 month schedule of Twinrix Paediatric in children aged
Croatian: U 10 godina nakon uvođenja rasporeda cijepljenja od 0, 1, 6 mjeseci cjepivom Twinrix Paediatric kod djece u dobi od 12 do 15 godina, svi praćeni ispitanici zadržali su anti-HAV protutijela ≥15 mIU/ml,
English: Vasculitis
Croatian: Hrvatska
English: Irritability
Croatian: Nuspojave
English: 10 pre-filled syringes + 20 needles 10 x 1 dose (0.5 ml)
Croatian: 10 napunjenih štrcaljki + 20 igli 10 x 1 doza (0,5 ml)
English: The following adverse reactions have been reported with either Twinrix or with GlaxoSmithKline monovalent hepatitis A or B vaccines:
Croatian: Praćenje nakon stavljanja cjepiva u promet Sljedeće su nuspojave prijavljene nakon primjene cjepiva Twinrix ili monovalentnih cjepiva protiv hepatitisa
English: NAME OF THE MEDICINAL PRODUCT Twinrix Paediatric - Suspension for injection in pre-filled syringe Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
Croatian: Uputa o lijeku: Informacija za korisnika Twinrix Paediatric, suspenzija za injekciju u napunjenoj štrcaljki Cjepivo protiv hepatitisa A (inaktiviranog) i hepatitisa B (rDNA) (HAB) (adsorbirano)
English: What you need to know before you receive Twinrix Paediatric
Croatian: Što morate znati prije nego primite cjepivo Twinrix Paediatric Twinrix Paediatric se ne smije dati ako:
English: 10 pre-filled syringes + 10 needles 10 x 1 dose (0.5 ml)
Croatian: 10 napunjenih štrcaljki + 10 igli 10 x 1 doza (0,5 ml)
English: 50 x 1 dose (0.5 ml)
Croatian: 50 napunjenih štrcaljki 50 x 1 doza (0,5 ml)
English: Side effects occured during clinical studies or routine use of the vaccine or with individual hepatitis A and hepatitis B vaccines or with the adult formulation of Twinrix.
Croatian: Mogu se pojaviti sljedeće nuspojave: Nuspojave zabilježene tijekom kliničkih ispitivanja ili rutinske primjene ovog cjepiva ili zasebnih cjepiva protiv hepatitisa
English: Uncommon Upper respiratory tract infection*
Croatian: Infekcije i infestacije manje često infekcija gornjih dišnih putova*
English: NAME OF THE MEDICINAL PRODUCT Twinrix Paediatric, suspension for injection Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed).
Croatian: Cjepivo protiv hepatitisa A (inaktiviranog) i hepatitisa B (rDNA) (HAB) (adsorbirano).
English: 10 x 1 dose (0.5 ml)
Croatian: 10 napunjenih štrcaljki 10 x 1 doza (0,5 ml)
English: - neomycin.
Croatian: • omaglica
English: GlaxoSmithKline S.p.A. Tel: + 39 (0)45 9218 111
Croatian: GlaxoSmithKline (GSK) SRL Tel: +40 (0)21 3028 208
English: Investigations
Croatian: PRIMJENU
English: This summary was last updated in 02-2016.
Croatian: Sažetak je posljednji put ažuriran: 02.2016.
English: The full EPAR for Zoledronic acid Actavis can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Zoledronatna kiselina Actavis nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Zoledronic acid Actavis.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet i svoje preporuke za uporabu lijeka Zoledronatna kiselina Actavis.
English: This means that Zoledronic acid Actavis is similar to a ‘reference medicine' already authorised in the European Union (EU) called Zometa.
Croatian: To znači da je lijek Zoledronatna kiselina Actavis sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Zometa.
English: It is available as a concentrate to be made into a solution for infusion (drip) into a vein.
Croatian: Dostupan je kao koncentrat od kojeg se priprema otopina za intravensku infuziju (drip).
English: This includes fractures (breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders needing radiotherapy (treatment with radiation) or surgery, and hypercalcaemia (high levels of calcium in the blood).
Croatian: To uključuje frakture (lomove kosti), spinalnu kompresiju (kada kost pritišće leđnu moždinu), koštane poremećaje koji zahtijevaju radioterapiju (terapiju zračenjem) ili kirurški zahvat te hiperkalcemiju (visoke koncentracije kalcija u krvi).
English: In addition, the company that markets Zoledronic acid Actavis will provide a card to inform patients about the risk of osteonecrosis of the jaw (damage to the bones of the jaw, which could lead to pain, sores in the mouth or loosening of teeth) and to instruct them to contact their doctor if they experience symptoms.
Croatian: Osim toga, tvrtka koja lijek Zoledronatna kiselina Actavis stavlja u promet bolesnicima će dati karticu s informacijama o riziku od osteonekroze čeljusti (oštećenje kosti čeljusti koje može uzrokovati bol, ranice u ustima ili klimanje zuba) i uputama o tome da se obrate svom liječniku ako primijete takve simptome.
English: The CHMP concluded that, in accordance with EU requirements, Zoledronic acid Actavis has been shown to be comparable to Zometa.
Croatian: CHMP je zaključio da je u skladu sa zahtjevima EU-a dokazano da je Zoledronatna kiselina Actavis usporediva s lijekom Zometa.
English: The usual dose of Zoledronic acid Actavis is one infusion of 4 mg over at least 15 minutes.
Croatian: Uobičajena doza lijeka Zoledronatna kiselina Actavis je jedna infuzija od 4 mg u trajanju od najmanje 15 minuta.
English: Because Zoledronic acid Actavis is a generic medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je Zoledronatna kiselina Actavis generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: For more information about treatment with Zoledronic acid Actavis, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Zoledronatna kiselina Actavis pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: This is a summary of the European public assessment report (EPAR) for Zoledronic acid Actavis.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Zoledronatna kiselina Actavis.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Zoledronic acid Actavis on 20 April 2012.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Zoledronatna kiselina Actavis na snazi u Europskoj uniji od 20. travnja 2012.
English: By preventing the breakdown of bones, Zoledronic acid Actavis also helps to reduce the amount of calcium released into the blood.
Croatian: Sprječavanjem loma kostiju Zoledronatna kiselina Actavis također pomaže u smanjenju količine kalcija koja se oslobađa u krv.
English: It is not recommended for patients with severe kidney problems.
Croatian: Lijek nije preporučljiv za bolesnike koji imaju ozbiljne probleme s bubrezima.
English: Zoledronic acid Actavis must only be used by a doctor who has experience in the use of this type of medicine given into a vein.
Croatian: Zoledronatnu kiselinu Actavis smije primjenjivati samo liječnik s iskustvom u uporabi ove vrste lijeka koji se daje u venu.
English: No additional studies were needed as Zoledronic acid Actavis is a generic medicine that is given by infusion and contains the same active substance as the reference medicine, Zometa.
Croatian: Nisu bila potrebna dodatna ispitivanja jer je Zoledronatna kiselina Actavis generički lijek koji se daje infuzijom i koji sadrži istu djelatnu tvar kao i referentni lijek Zometa.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Zoledronic acid Actavis, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Zoledronatna kiselina Actavis nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: Zoledronic acid Actavis can also be used to treat the hypercalcaemia caused by tumours.
Croatian: Zoledronatna kiselina Actavis može se također koristiti za liječenje hiperkalcemije uzrokovane tumorima.
English: Zoledronic acid Actavis can be used to prevent bone complications in adults with advanced cancer that is affecting the bone.
Croatian: Zoledronatna kiselina Actavis može se koristiti za sprječavanje koštanih komplikacija u odraslih osoba s uznapredovalim rakom koji zahvaća kosti.
English: Zoledronic acid Actavis is a ‘generic medicine'.
Croatian: Zoledronatna kiselina Actavis je „generički lijek”.
English: A risk management plan has been developed to ensure that Zoledronic acid Actavis is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Zoledronatna kiselina Actavis.
English: The company provided data from the published literature on zoledronic acid.
Croatian: Tvrtka je dostavila podatke o Zoledronatnoj kiselini iz objavljene literature.
English: What measures are being taken to ensure the safe and effective use of Zoledronic acid Actavis?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Zoledronatna kiselina Actavis?
English: The Committee recommended that Zoledronic acid Actavis be given marketing authorisation.
Croatian: Odbor je preporučio da se izda odobrenje za stavljanje u promet lijeka Zoledronatna kiselina Actavis.
English: The active substance in Zoledronic acid Actavis, zoledronic acid, is a bisphosphonate.
Croatian: Djelatna tvar u lijeku Zoledronatna kiselina Actavis, zoledronatna kiselina, je bisfosfonat.
English: Zoledronic acid Actavis zoledronic acid
Croatian: Zoledronatna kiselina Actavis zoledronatna kiselina
English: Zoledronic acid Actavis is a medicine that contains the active substance zoledronic acid (4 mg).
Croatian: Zoledronatna kiselina Actavis lijek je koji sadrži zoledronatnu kiselinu (4 mg) kao djelatnu tvar.
English: Other information about Zoledronic acid Actavis
Croatian: Ostale informacije o lijeku Zoledronatna kiselina Actavis
English: What are the benefits and risks of Zoledronic acid Actavis?
Croatian: Koje su koristi i rizici od lijeka Zoledronatna kiselina Actavis?
English: Therefore, the CHMP's view was that, as for Zometa, the benefit outweighs the identified risk.
Croatian: Stoga je stav CHMP-a kako koristi nadmašuju utvrđeni rizik, kao i kod lijeka Zometa.
English: When used to prevent bone complications, the infusion can be repeated every three to four weeks, and patients should also take supplements of calcium and vitamin D. A lower dose is recommended for patients with bone metastases (when cancer has spread to the bone) if they have mild to moderate problems with their kidneys.
Croatian: Ako se koristi za sprječavanje koštanih komplikacija, infuzija se može ponoviti svaka tri do četiri tjedna, a bolesnik treba također uzimati dopunske pripravke kalcija i vitamina D.
English: Why has Zoledronic acid Actavis been approved?
Croatian: Zašto je lijek Zoledronatna kiselina Actavis odobren?
English: What is Zoledronic acid Actavis?
Croatian: Što je Zoledronatna kiselina Actavis?
English: What is Zoledronic acid Actavis used for?
Croatian: Za što se Zoledronatna kiselina Actavis koristi?
English: How is Zoledronic acid Actavis used?
Croatian: Kako se koristi Zoledronatna kiselina Actavis?
English: How does Zoledronic acid Actavis work?
Croatian: Kako djeluje Zoledronatna kiselina Actavis?
English: How has Zoledronic acid Actavis been studied?
Croatian: Kako je lijek Zoledronatna kiselina Actavis ispitivan?
English: You may require a blood transfusion.
Croatian: Možda će Vam trebati transfuzija krvi.
English: - Sudden death.
Croatian: - Iznenadna smrt.
English: if you are pregnant.
Croatian: - ako ste trudni.
English: Distribution into testes is relatively low.
Croatian: Distribucija u testise je relativno mala.
English: Time to recovery
Croatian: Vrijeme do oporavka
English: Do not give this medicine to children and adolescents from birth up to age of 18 years as safety and efficacy in children and adolescents have not been established.
Croatian: Nemojte davati ovaj lijek djeci i adolescentima u dobi od rođenja do 18 godina jer sigurnost i djelotvornost u djece i adolescenata nije ustanovljena.
English: Plasma concentrations decrease rapidly during the first two hours and slowly thereafter.
Croatian: Koncentracije u plazmi smanjuje se brzo tijekom prva dva sata, a nakon toga sporije.
English: In men, no data are available.
Croatian: Za muškarce nema dostupnih podataka.
English: - Changes in weight.
Croatian: - Promjene u težini.
English: There is little experience in children and adolescents.
Croatian: Postoji malo iskustva u djece i adolescenata.
English: There are insufficient data that allows for dose adjustment recommendations.
Croatian: Nema dovoljno podataka koji omogućuju preporuke za prilagodbu doze.
English: If this happens, the infusion must be stopped and restarted in another vein.
Croatian: Ako se to dogodi, infuzija se mora zaustaviti i ponovo započeti u drugoj veni.
English: The product information may be subsequently updated by the Member State competent authorities, in liaison with the Reference Member State, as appropriate, in accordance with the procedures laid down in Chapter 4 of Title III of Directive 2001/83/EC.
Croatian: Informacije o lijeku mogu biti naknadno ažurirane od strane nadležnih tijela država članica, u dogovoru s referentnom državom članicom, ako je prikladno, u skladu s postupcima navedenima u Poglavlju 4 Glave III Direktive 2001/83/EZ.
English: Contraception in men and women
Croatian: Kontracepcija u muškaraca i žena
English: In addition your blood will be tested regularly during the treatment.
Croatian: Povrh toga, redovito će se ispitivati Vaša krv tijekom liječenja.
English: • if you already use other medicines that affect your heart;
Croatian: • ako već primjenjujete druge lijekove koji utječu na Vaše srce;
English: The dosage of the medicine will be adjusted in accordance with the results of these tests.
Croatian: Doziranje lijeka prilagodit će se u skladu s rezultatima ovih pretraga.
English: Many of the reported half-life values for the elimination phase are between 10 and 40 hours, but several other authors have reported much longer values of between 7 and 12 days.
Croatian: Mnoge od prijavljenih vrijednosti poluvijeka za fazu eliminacije iznose između 10 i 40 sati, ali nekoliko drugih autora prijavilo je mnogo dulje vrijednosti između 7 i 12 dana.
English: If you suffer from these side effects, do not drive any vehicles and/or use any machines.
Croatian: Ako patite od ovih nuspojava, nemojte upravljati vozilima i/ili raditi sa strojevima.
English: Infection (including fatal outcome)
Croatian: Infekcija (uključujući smrtni ishod)
English: Like all medicines, this medicine can cause side effects, although not everybody gets them.
Croatian: Kao i svi lijekovi ovaj lijek može uzrokovati nuspojave iako se one neće javiti kod svakoga.
English: UNIQUE IDENTIFIER - 2D BARCODE <Not applicable>
Croatian: 17. JEDINSTVENI IDENTIFIKATOR - 2D BARKOD <Nije primjenjivo>
English: Recovery > 21 days
Croatian: Oporavak > 21 dan
English: Therefore you should talk to your doctor if you are planning to become pregnant in the future; your eggs may need to be frozen.
Croatian: Stoga je nužno da obavijestite svog liječnika ako planirate zatrudnjeti u budućnosti; možda će biti potrebno zamrznuti Vaše jajne stanice.
English: - Blood poisoning (sepsis).
Croatian: - Otrovanje krvi (sepsa).
English: - Loss of appetite.
Croatian: - Gubitak apetita.
English: Of the material recovered in urine, 65 % was unchanged active substance.
Croatian: Od materijala nađenog u mokraći 65% je bila nepromijenjena djelatna tvar.
English: Repeat prior dose
Croatian: Ponoviti prijašnju dozu
English: - New or worsening breathing difficulties.
Croatian: - novo ili pogoršanje otežanog disanja;
English: Other medicines and Novantrone
Croatian: Drugi lijekovi i Novantrone
English: In each individual case the benefit of treatment must be weighed up against the possible risk to the foetus.
Croatian: U svakom pojedinačnom slučaju mora se odvagnuti korist liječenja naspram mogućeg rizika za fetus.
English: Phlebitis has also been reported at the site of infusion.
Croatian: Flebitis je također prijavljen na mjestu infuzije.
English: The first course was given approximately 6 weeks after the final induction course; the second was generally administered 4 weeks after the first.
Croatian: Prvi ciklus se dao približno 6 tjedana nakon završnog ciklusa indukcije; drugi se uglavnom primijenjivao 4 tjedna nakon prvog.
English: - Fever or infections.
Croatian: - vrućica ili infekcije.
English: Talk to your doctor or, pharmacist or nurse before using Novantrone:
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego primijenite Novantrone:
English: Adjustments of the anticoagulant dose may be necessary in order to maintain the desired level of anticoagulation.
Croatian: Prilagodbe doze antikoagulansa mogu biti neophodne radi održavanja željene razine antikoagulacije.
English: UNIQUE IDENTIFIER - HUMAN READABLE DATA <Not applicable>
Croatian: JEDINSTVENI IDENTIFIKATOR - PODACI ČITLJIVI LJUDSKIM OKOM <Nije primjenjivo>
English: Your doctor will decide precisely which subsequent dosage you need.
Croatian: Vaš će liječnik precizno odlučiti koje naknadno doziranje trebate.
English: Novantrone may cause damage to your unborn child.
Croatian: Novantrone može naštetiti Vašem nerođenom djetetu.
English: Its therapeutic efficacy has been reported in numerous malignancies.
Croatian: Njegova terapijska djelotvornost prijavljena je u brojnim zloćudnim bolestima.
English: - Heavy bleeding.
Croatian: - Teško krvarenje.
English: Particular care should be given to assuring full haematological recovery before undertaking consolidation therapy (if this treatment is used) and patients should be monitored closely during this phase.
Croatian: Posebnu pažnju je potrebno posvetiti osiguranju potpunog hematološkog oporavka prije provođenja konsolidacijske terapije (ako se ovo liječenje primijeni), a bolesnike je potrebno strogo pratiti tijekom ove faze.
English: You are more prone to these side effects if you take higher doses of Novantrone or:
Croatian: Skloniji ste ovim nuspojavama ako uzimate veće doze Novantrona ili:
English: Cases of ECG anomalies have been reported.
Croatian: Prijavljeni su slučajevi anomalija EKG-a.
English: This may occur either during or months to years after therapy with Novantrone.
Croatian: To se može pojaviti bilo tijekom ili mjesecima do godinama nakon terapije Novantronom.
English: Withhold until recovery, then repeat prior dose.
Croatian: Obustaviti liječenje do oporavka, potom ponoviti prijašnju dozu.
English: If used alone for recurrence (return of the cancer)
Croatian: Ako se primjenjuje samostalno za rekurenciju (povratak raka)
English: A reversible thrombocytopenia can also be observed.
Croatian: Reverzibilna trombocitopenija također se može opaziti.
English: - Infections caused by microorganisms which do not normally cause diseases with a healthy immune system (opportunistic infections).
Croatian: - Infekcije uzrokovane mikroorganizmima koji obično ne uzrokuju bolesti u slučaju zdravog imunološkog sustava (oportunističke infekcije).
English: Ask your doctor or pharmacist if you are not sure whether your medicine is one of the medicines listed above.
Croatian: Obratite se svom liječniku ili ljekarniku ako niste sigurni je li Vaš lijek jedan od prethodno navedenih lijekova.
English: • if you use Novantrone in high doses (>14 mg/m2 per day x 3 days).
Croatian: • ako primjenjujete Novantrone u velikim dozama (>14 mg/m2 na dan x 3 dana).
English: Patients should be informed about risks, symptoms and signs of acute leukaemia and prompted to seek medical attendance if any such symptoms should occur even after the five year period has passed.
Croatian: Bolesnike je potrebno obavijestiti o rizicima, simptomima i znakovima akutne leukemije i potaknuti ih da potraže medicinsku pomoć ako se navedeni simptomi pojave čak i po isteku razdoblja od pet godina.
English: If you are taking any of these, your doctor might need to prescribe an alternative medicine for you.
Croatian: Ako uzimate bilo koji od njih, liječnik Vam može propisati zamjenski lijek.
English: What Novantrone is and what it is used for
Croatian: Što je Novantrone i za što se koristi
English: If possible, avoid veins over joints or in extremities with compromised venous or lymphatic drainage.
Croatian: Ako je moguće, izbjegavati vene preko zglobova ili u ekstremitetima s kompromitiranom venskom ili limfnom drenažom.
English: Also the time course over which the cumulative dose was given ranged from 3 to 24 months.
Croatian: Također vremenski tijek tijekom kojeg se davala kumulativna doza kretao se u rasponu od 3 do 24 mjeseca.
English: These medicines should be used with care or may need to be avoided during your treatment with Novantrone.
Croatian: Ovi se lijekovi trebaju primjenjivati s oprezom ili bi moglo biti potrebno izbjegavati ih tijekom Vašeg liječenja Novantronom.
English: No effects were observed on pup development or fertility in the two generation study in rats.
Croatian: Nisu opaženi učinci na razvoj mladunčadi ili plodnost u ispitivanju dviju generacija na štakorima.
English: - Tiredness, weakness and lack of energy.
Croatian: - Umor, slabost i nedostatak energije.
English: It has a cytocidal effect on both proliferating and non-proliferating cultured human cells, suggesting lack of cell cycle phase specificity and activity against rapidly proliferating and slow-growing neoplasms.
Croatian: Ima citocidni učinak kako na proliferirajuće tako i na neproliferirajuće humane stanice u kulturi što sugerira nedostatak specifičnosti za faze staničnog ciklusa i aktivnost protiv brzo proliferirajućih i sporo rastućih neoplazmi.
English: You should also tell your doctor if you are already taking Novantrone and you are prescribed a new medicine that you have not already taken at the same time as Novantrone.
Croatian: Također trebati obavijestiti svog liječinka ako već uzimate Novantrone, a propisan Vam je novi lijek koji još niste uzeli u isto vrijeme s Novantronom.
English: Your doctor may need to adjust your treatment or stop Novantrone temporarily or permanently.
Croatian: Vaš liječnik će možda morati prilagoditi liječenje Novantronom ili ga privremeno ili trajno prekinuti.
English: Differences in the estimates may be due to the availability of data at late times after doses, weighing of the data and assay sensitivity.
Croatian: Razlike u procjenama mogu biti uslijed raspoloživosti podataka u kasnijim vremenima nakon doza, ponderiranja podataka i osjetljivosti testa.